(Q44102597)

29 November 2017

title

Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells (English)

1 reference

29 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585143

neoplastic gene expression regulation

25 May 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585143

25 May 2024

R. A. DePinho

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585143

25 May 2024

J. Chen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585143

25 May 2024

T. Willingham

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585143

25 May 2024

L. R. Margraf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585143

25 May 2024

N. Schreiber-Agus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585143

25 May 2024

P. D. Nisen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585143

25 May 2024

language of work or name

English

0 references

publication date

1 July 1995

1 reference

full work available at URL

29 November 2017

http://www.nature.com/articles/nm0795-638

1 reference

https://api.crossref.org/works/10.1038/NM0795-638

http://www.nature.com/articles/nm0795-638.pdf

25 May 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/NM0795-638

25 May 2024

1 reference

29 November 2017

1 reference

29 November 2017

1 reference

29 November 2017

page(s)

638-643

1 reference

The regulation and expression of c-myc in normal and malignant cells

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

Repression of cyclin D1: a novel function of MYC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

21 January 2018

Oncogenes and cell death

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

The human myc gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

7 January 2021

myc family oncogenes in the development of normal and neoplastic cells.

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

7 January 2021

Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

7 January 2021

Sequence-specific DNA binding by the c-Myc protein

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

7 January 2021

Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

7 January 2021

Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

7 January 2021

Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

7 January 2021

Myc and Max associate in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

7 January 2021

An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

7 January 2021

Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

7 January 2021

A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

7 January 2021

Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

7 January 2021

Manipulation of adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

7 January 2021

Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

7 January 2021

Stabilization of c-myc protein in human glioma cells.

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

7 January 2021

The role of c-myc in cell growth

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

7 January 2021

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://api.crossref.org/works/10.1038%2FNM0795-638

7 January 2021

https://api.crossref.org/works/10.1038/NM0795-638

G Clayman

1995

1 reference

25 May 2024

Identifiers

DOI

10.1038/NM0795-638

1 reference

29 November 2017

1 reference